72,234 articles
Michael J. Donoghue
Michael J. Donoghue (born 1952) is an American evolutionary biologist and plant systematist, a Sterling Professor Emeritus at Yale known for applying phylogenetic trees to morphology and biogeography.
Michael J. Eck
Michael J. Eck is an American structural biologist and cancer researcher at Dana-Farber Cancer Institute and Harvard Medical School, known for kinase structures and EGFR lung-cancer drugs.
Michael J. Fine
Michael J. Fine is an American general internist and health services researcher, Emeritus Professor of Medicine at the University of Pittsburgh, who developed the Pneumonia Severity Index in 1997.
Michael J. Frank
Michael J. Frank is an American cognitive and computational neuroscientist at Brown University known for research on reinforcement learning, decision making, and dopamine in Parkinson's disease.
Michael J. Gale
Michael J. Gale is an American immunologist who defined the RIG-I pathway of viral RNA sensing and directs the University of Minnesota Institute on Infectious Diseases.
Michael J. Getz
Michael J. Getz (1944–1999) was an American molecular biologist who spent his career at Mayo Clinic, known for RNA sequence complexity work and retroviral LTR gene regulation.
Michael J. Hayman
Michael J. Hayman is a molecular biologist and Professor Emeritus at Stony Brook University, known for identifying the erbB oncogene product as a membrane glycoprotein.
Michael J. Holtzman
Michael J. Holtzman is an American physician-scientist in pulmonary immunology at Washington University in St. Louis, who led its pulmonary division from 1992 to 2022.
Michael J. Kahana
Michael J. Kahana, also known as Michael Kahana, is a cognitive neuroscientist and professor of psychology at the University of Pennsylvania who studies how the brain forms and retrieves memories.
Michael J. Keating
Michael J. Keating is an Australian-born hematologist-oncologist who spent nearly five decades at MD Anderson Cancer Center, developing the FCR regimen that transformed chronic lymphocytic leukemia treatment.
Michael J. Klag
Michael J. Klag is an American physician and epidemiologist who led the Johns Hopkins Precursors Study and served as the 10th dean of the Bloomberg School of Public Health.
Michael J. Krashes
Michael J. Krashes is an American neuroscientist who studies the brain circuits driving hunger, leading a research section at the National Institutes of Health in Bethesda, Maryland.
Michael J. Kuhar
Michael J. Kuhar is an American neuropharmacologist who mapped opiate receptors and showed in 1987 that cocaine binds the dopamine transporter, then spent his career at Emory University.
Michael J. Lenardo
Michael J. Lenardo is an American physician-scientist and molecular immunologist at NIH in Bethesda, Maryland, known for discovering the genetic basis and treatment of congenital immune disorders.
Michael J. Mack
Michael J. Mack is an American cardiothoracic surgeon in Dallas whose SYNTAX and PARTNER trials helped establish transcatheter aortic valve replacement, and who co-led the COAPT mitral repair trial.
Michael J. Meaney
Michael J. Meaney, also known as Michael Meaney, is a Canadian behavioral neuroscientist at McGill University known for showing how maternal care shapes stress responses for life.
Michael J. Novacek
Michael J. Novacek is an American paleontologist and curator at the American Museum of Natural History since 1982, known for Gobi Desert expeditions and research on early mammal evolution.
Michael J. Reardon
Michael J. Reardon is an American cardiothoracic surgeon at Houston Methodist in Houston, Texas, known for leading the randomized trials that established TAVR as an alternative to open-heart surgery.
Michael J. Seckl
Michael J. Seckl is a British medical oncologist, Professor of Molecular Oncology at Imperial College London, who directs the national Gestational Trophoblastic Disease Service and developed the TE/TP regimen.
Michael J. Smerdon
Michael J. Smerdon is an American biochemist who founded the study of DNA repair in chromatin, the packaged form of DNA, during a long career at Washington State University.
Michael J. Sofia
Michael J. Sofia is an American medicinal chemist who led the Pharmasset team that discovered sofosbuvir, the hepatitis C cure credited to more than 10 million patients.
Michael J. Thun
Michael J. Thun is an American cancer epidemiologist who spent 1989 to 2012 at the American Cancer Society, known for studies on aspirin's role in cancer prevention.
Michael J. Weber
Michael J. Weber (1942–2021) was an American molecular biologist and cancer biologist who helped discover MAP kinase and directed the University of Virginia Cancer Center from 2000 to 2013.
Michael J. Welsh
Michael J. Welsh is an American physician-scientist at the University of Iowa who showed the CFTR protein is a chloride channel, enabling CFTR-modulator drugs for cystic fibrosis.
Michael J.G. Farthing
Michael J.G. Farthing, also known as M.J.G. Farthing, is a British gastroenterologist and parasitologist, honorary professor at UCL, editor of Gut, and founding chairman of COPE.
Michael James Denham White
Michael James Denham White (1910–1983) was a British-born zoologist and geneticist, a leading figure in animal cytogenetics and foundation professor of genetics at the University of Melbourne.
Michael John Bevan
Michael John Bevan, born in 1945, is a cellular immunologist known for discovering positive selection of T cells in the thymus and cross-priming, and a University of Washington professor.
Michael K. Gilson
Michael K. Gilson is a computational chemist, Professor and Chair in Computer-Aided Drug Design at UC San Diego since 2010, known for creating BindingDB and the Mining Minima method.
Michael K. Gould
Michael K. Gould is an American pulmonologist and health services researcher at Kaiser Permanente in California, known for his 2014 New England Journal of Medicine review of low-dose CT lung-cancer screening.
Michael K. Mansour
Michael K. Mansour is an infectious-diseases physician-scientist at Massachusetts General Hospital and Harvard Medical School, known for research on how the immune system recognizes fungal pathogens and for a 2020 tocilizumab Covid-19 trial.